AstraZeneca’s Covid drug loses authorization in Brazil due to lack of efficacy
On Tuesday (Mar. 7), Brazil's National Health Regulator (Anvisa) temporarily suspended the authorization for emergency use of the drug
March 8, 2023
On Tuesday (Mar. 7), Brazil's National Health Regulator (Anvisa) temporarily suspended the authorization for emergency use of the drug
March 8, 2023
The Global Covid Summit, comprising over 17,000 physicians and scientists, held a press conference highlighting the Summit’s declaration
May 12, 2022
Argentina has struck a deal with drugmaker AstraZeneca Plc to receive around 22 million doses of its COVID-19 vaccine being...
November 7, 2020